Methanesulfonamide, N-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl-1,1,1-trifluoro-, compd. with N,N-diethylethanamine (1:1)

Methanesulfonamide, N-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl-1,1,1-trifluoro-, compd. with N,N-diethylethanamine (1:1) Struktur
1150111-92-4
CAS-Nr.
1150111-92-4
Englisch Name:
Methanesulfonamide, N-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl-1,1,1-trifluoro-, compd. with N,N-diethylethanamine (1:1)
Synonyma:
N-[Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl]-1,1,1-trifluoromethanesulfonamide triethylamine adduct;Methanesulfonamide, N-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl-1,1,1-trifluoro-, compd. with N,N-diethylethanamine (1:1)
CBNumber:
CB211089209
Summenformel:
C27H28F3N2O4PS
Molgewicht:
564.56
MOL-Datei:
1150111-92-4.mol

Methanesulfonamide, N-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl-1,1,1-trifluoro-, compd. with N,N-diethylethanamine (1:1) Eigenschaften

Sicherheit

Methanesulfonamide, N-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl-1,1,1-trifluoro-, compd. with N,N-diethylethanamine (1:1) Chemische Eigenschaften,Einsatz,Produktion Methoden

Methanesulfonamide, N-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl-1,1,1-trifluoro-, compd. with N,N-diethylethanamine (1:1) Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Methanesulfonamide, N-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl-1,1,1-trifluoro-, compd. with N,N-diethylethanamine (1:1) Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 1)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Tianjin Derchemist Science & Technology Co., Ltd. 22-58627059 13920586291
zdcomcon@126.com China 3166 50

  • Methanesulfonamide, N-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl-1,1,1-trifluoro-, compd. with N,N-diethylethanamine (1:1)
  • N-[Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl]-1,1,1-trifluoromethanesulfonamide triethylamine adduct
  • 1150111-92-4
Copyright 2019 © ChemicalBook. All rights reserved